Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Organ-On-Chip Global Market 2018 - Emulate, CN-Bio Innovations, InSphero, Mimetas, TissUse, Hrel, and Nortis Dominating the Industry - Research and Markets

Research and Markets
Posted on: 05 Jan 18

The "Organ-On-Chip Global Market 2018" report has been added to Research and Markets' offering.

The global market for OOCs was valued at $20 million in 2016. It is expected to grow at a compound annual growth rate (CAGR) of 70% to reach $284 million by 2021.

The small size of the market is mainly due to the fact that OOCs have not yet been fully commercialized. They are still in the research and development phase and are primarily being used by a limited number of end-users. The OOC market is expected to rise at this high CAGR due to an increase in the number of collaborative sales agreements between the pharmaceutical companies and university spin-offs and the entry of new advanced models of OOCs into the market. The anticipated launch of advanced organ-specific models and human-on-chip models is expected to further increase the growth rate of this market in future.

OOC technology is still at an initial stage of research, development and commercialization. The players in the market are primarily university spinoffs involved in the commercialization of OOC prototypes developed in the universities. The key players include Emulate, CN-Bio Innovations, InSphero, Mimetas, TissUse, Hrel and Nortis. Currently OOCs are marketed primarily through sales agreements with end-users that involve collaboration of both parties in tailoring the OOCs to meet the end-user's requirements. Currently OOCs are marketed primarily through sales agreements with end-users that involve collaboration of both parties in tailoring the OOCs to meet the end-user's requirements.

Companies Mentioned:

  • Ascendance
  • AxoSim Techologies LLC
  • CN Bio Innovations
  • Emulate Inc.
  • HemoShear
  • HREL Corporation (HREL)
  • InSphero
  • Mimetas
  • Nortis
  • Organovo
  • Tara Biosystems
  • TissUse GmbH

Key Topics:

  • Scope of the Report
  • Sections
  • Introduction
  • Product Analysis
  • Market Characteristics and Trends
  • Market Drivers and Restraints
  • Market Size Analysis
  • Funding Landscape
  • Competitive Landscape
  • Business Model
  • Customer Analysis

For more information about this report visit https://www.researchandmarkets.com/research/79z7sm/organonchip?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180105005519/en/

Business Wire
www.businesswire.com

Last updated on: 05/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.